drugset / Trial / NCT00003982

MEN-10755 in Treating Patients With Solid Tumors

NCT00003982 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of MEN-10755 in treating patients who have solid tumors.

Timeline

Start
1997-06
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject sabarubicin Small molecule — Intravenous